title: Unexpected cardiotoxicity in haematological bortezomib treated patients.
authors.forename: Orciuolo
authors.initials: O
authors.lastname: Enrico
authors.forename: Buda
authors.initials: B
authors.lastname: Gabriele
authors.forename: Cecconi
authors.initials: C
authors.lastname: Nadia
authors.forename: Galimberti
authors.initials: G
authors.lastname: Sara
authors.forename: Versari
authors.initials: V
authors.lastname: Daniele
authors.forename: Cervetti
authors.initials: C
authors.lastname: Giulia
authors.forename: Salvetti
authors.initials: S
authors.lastname: Antonio
authors.forename: Petrini
authors.initials: P
authors.lastname: Mario
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced* / Q000276:immunology; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy; D011480:Protease Inhibitors / Q000009:adverse effects*; D011719:Pyrazines / Q000009:adverse effects*
chemical_list: D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib